Acid Concentrate D12236 263 g (Sodium Chloride SOLUTION) 263 G

Sodium Chloride Solution 263 G is a concentrated solution used in haemodialysis. This sterile solution is designed for medical use and is manufactured by Vantive ULC in Canada.

Strength

263 G

Pack Size

4.5 L

Manufacturer / TM Owner

VANTIVE ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sodium Chloride Solution 263 G is primarily used in haemodialysis procedures. Haemodialysis is a process that helps filter waste and excess fluids from the blood when the kidneys are not functioning properly. This solution is formulated to maintain the electrolyte balance during the dialysis process, supporting overall patient well-being.

Side Effects

When used as directed in haemodialysis, Sodium Chloride Solution 263 G helps to maintain the necessary electrolyte balance in the body. It is designed to work in conjunction with dialysis machines to ensure effective filtration of waste products from the blood.

Precautions & Warnings

Sodium Chloride Solution 263 G should be handled with care and used only under the supervision of a healthcare professional. Ensure that the solution is stored properly and that the packaging is not damaged. Always check the expiration date before use.

Avoid Interactions

Sodium Chloride Solution 263 G may interact with other medications or solutions used during haemodialysis. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always follow the instructions provided by your healthcare professional.

Frequently Asked Questions

Sodium Chloride Solution 263 G is used in haemodialysis to help filter waste and excess fluids from the blood when the kidneys are not functioning properly.

Sodium Chloride Solution 263 G should be stored in a cool, dry place away from direct sunlight and heat sources. Ensure the packaging is intact and check the expiration date regularly.

Sodium Chloride Solution 263 G may interact with other medications. Always consult your healthcare provider before using it with other treatments.

When used in haemodialysis, Sodium Chloride Solution 263 G helps maintain electrolyte balance and supports the filtration of waste products from the blood.

Sodium Chloride Solution 263 G is manufactured by Vantive ULC in Canada.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.